Share on LinkedInShare on LinkedIn

ARTICLE · 08 JUNE 2016

Developing A Patent Family Bigger Than The Brady Bunch

New drugs require a huge amount of innovation, time, capital and risk to get to market. Nobody should begrudge a drug company for seeking strong patent protection.

CanadaIntellectual Property

New drugs require a huge amount of innovation, time, capital and risk to get to market. Nobody should begrudge a drug company for seeking strong patent protection. Without it, generic drug copies would quickly flood the market, and the original drug manufacturer would lose money and go out of business. Patents help ensure that innovators thrive, so we get more of the R&D that is necessary to develop future drugs. Once the patents on a drug expire, the drug is public domain and any generic company is free to make its own version (subject to regulatory exclusivities, which will not be discussed here).

There is rarely a single patent on a new blockbuster drug. The initial patent will often focus on the drug compound itself, methods of manufacture and the known medical uses. Improvements are then captured, such as formulations that may provide greater stability or desired drug delivery properties. Combinations with other drugs may be made that provide better clinical

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from